- Home
- Profiles
Ajai Chari, MD
- About Me
- Clinical Focus
- Awards
- Publications
- Industry Relationships
About Me
Language
Position
About Me
Language
Position
Clinical Focus
- AL Amyloidosis
- Amyloidosis
- Bone Marrow Transplantation
- Bone Marrow Transplantation, Autologous
- Hematologic Malignancies
- Multiple Myeloma
- Plasma Cell Neoplasms
- Waldenström's Macroglobulinemia
- AL Amyloidosis
- Amyloidosis
- Bone Marrow Transplantation
- Bone Marrow Transplantation, Autologous
- Hematologic Malignancies
- Multiple Myeloma
- Plasma Cell Neoplasms
- Waldenström's Macroglobulinemia
Awards
2013
Health Care Provider of the Year, Leukemia Lymphoma Society
2008
Ewig Teaching Award, Deparatment of Medicine, Columbia University College of Physicians and Surgeons
1994
Phi Beta Kappa, Stanford University
Best Junior Faculty Teacher Award, selected by 2008 Internal Medicine residency class, Columbia University College of Physicians and Surgeons
New York Metro Super Doctors 2011-2015
Publications
Selected Publications
- Correction to: GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review (Blood Cancer Journal, (2024), 14, 1, (24), 10.1038/s41408-023-00966-9). Paula Rodriguez-Otero, Niels W.C.J. van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Philippe Moreau, Nizar Bahlis, Ajai Chari. Blood Cancer Journal
- GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Paula Rodriguez-Otero, Niels W.C.J. van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Philippe Moreau, Nizar Bahlis, Ajai Chari. Blood Cancer Journal
- Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study. Thomas G. Martin, Philippe Moreau, Saad Z. Usmani, Alfred Garfall, María Victoria Mateos, Jesús F. San-Miguel, Albert Oriol, Ajay K. Nooka, Laura Rosinol, Ajai Chari, Lionel Karlin, Amrita Krishnan, Nizar Bahlis, Rakesh Popat, Britta Besemer, Joaquín Martínez-López, Michel Delforge, Danielle Trancucci, Lixia Pei, Rachel Kobos, John Fastenau, Katharine S. Gries, Niels W.C.J. van de Donk. Clinical Lymphoma, Myeloma and Leukemia
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Chari has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.